Literature DB >> 22055990

AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.

Sidney C Smith, Emelia J Benjamin, Robert O Bonow, Lynne T Braun, Mark A Creager, Barry A Franklin, Raymond J Gibbons, Scott M Grundy, Loren F Hiratzka, Daniel W Jones, Donald M Lloyd-Jones, Margo Minissian, Lori Mosca, Eric D Peterson, Ralph L Sacco, John Spertus, James H Stein, Kathryn A Taubert.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22055990     DOI： 10.1016/j.jacc.2011.10.824

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  210 in total

1.  Mindfulness-Based Interventions for Weight Loss and CVD Risk Management.

Authors:  Carl Fulwiler; Judson A Brewer; Sinead Sinnott; Eric B Loucks
Journal:  Curr Cardiovasc Risk Rep       Date:  2015-08-29

Review 2.  The potential role of endogenous bacteriophages in controlling invading pathogens.

Authors:  Andrzej Górski; Beata Weber-Dabrowska
Journal:  Cell Mol Life Sci       Date:  2005-03       Impact factor: 9.261

3.  Effects of partners together in health intervention on physical activity and healthy eating behaviors: a pilot study.

Authors:  Bernice C Yates; Joseph Norman; Jane Meza; Kaye Stanek Krogstrand; Susana Harrington; Scott Shurmur; Matthew Johnson; Karen Schumacher
Journal:  J Cardiovasc Nurs       Date:  2015 Mar-Apr       Impact factor: 2.083

4.  Participation Rates, Process Monitoring, and Quality Improvement Among Cardiac Rehabilitation Programs in the United States: A NATIONAL SURVEY.

Authors:  Quinn R Pack; Ray W Squires; Francisco Lopez-Jimenez; Steven W Lichtman; Juan P Rodriguez-Escudero; Peter K Lindenauer; Randal J Thomas
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 May-Jun       Impact factor: 2.081

Review 5.  Antagonist molecules in the treatment of angina.

Authors:  Ashish K Gupta; David Winchester; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2013-09-18       Impact factor: 3.889

6.  Life Years Gained From Smoking-Cessation Counseling After Myocardial Infarction.

Authors:  Emily M Bucholz; Adam L Beckman; Catarina I Kiefe; Harlan M Krumholz
Journal:  Am J Prev Med       Date:  2016-09-28       Impact factor: 5.043

7.  Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Chintan S Desai; Hongyan Ning; Joseph Kang; Aaron R Folsom; Joseph F Polak; Christopher T Sibley; Russell Tracy; Donald M Lloyd-Jones
Journal:  Am J Cardiol       Date:  2013-03-15       Impact factor: 2.778

Review 8.  Exercise training in cancer related cardiomyopathy.

Authors:  Julian G Westphal; P Christian Schulze
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 9.  The cholesterol emboli syndrome in atherosclerosis.

Authors:  Adriana Quinones; Muhamed Saric
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

10.  Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Authors:  Tanya N Turan; Jenifer H Voeks; Marc I Chimowitz; Ana Roldan; Todd LeMatty; William Haley; Maria Lopes-Virella; Seemant Chaturvedi; Michael Jones; Donald Heck; George Howard; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.